Home About

Trifena

DICLOFENAC, LIDOCAINE, MENTHOL

Manufacturer: Trifluent Pharma LLC

Score: 143.89

Quick Summary

Trifena patch is a topical pain relief medication containing diclofenac sodium, lidocaine, and menthol, used for temporary relief of pain associated with arthritis, backache, cramps, discomfort, neck ache, soreness, sprains, and strains. It should be applied to intact skin and used with caution in patients with certain medical conditions, such as asthma, heart failure, or liver disease. The medication has potential interactions with other drugs, including anticoagulants, aspirin, and diuretics, and may cause adverse reactions, such as skin irritation, gastrointestinal bleeding, or cardiovascular events.

Key Clinical Findings and Indications

  • Temporary relief of pain associated with arthritis, backache, cramps, discomfort, neck ache, soreness, sprains, and strains
  • Topical application to intact skin

Important Safety Information

Warning

Risk of serious cardiovascular and gastrointestinal events

Contraindications

  • Known hypersensitivity to diclofenac
  • Asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs
  • Severe heart failure
  • Non-intact or damaged skin

Adverse Reactions

  • Skin irritation
  • Gastrointestinal bleeding
  • Cardiovascular events
  • Hepatotoxicity

Dosing Recommendations

General Guidance

No specific dose adjustments recommended, but caution advised in patients with certain medical conditions

Pain relief

Adult Dose

Apply to intact skin, up to 2 times daily, for no longer than 12 hours per application

Pediatric Dose

Special Population Considerations

Pregnancy

  • Category C prior to 30 weeks gestation
  • Category D starting 30 weeks gestation
  • Avoid use in pregnant women starting at 30 weeks of gestation

Nursing Mothers

  • Diclofenac may be present in human milk
  • Caution advised when using in nursing mothers

Pediatric Use

  • Safety and effectiveness not established in pediatric patients

Geriatric Use

  • Elderly patients at greater risk for NSAID-associated serious cardiovascular, gastrointestinal, and/or renal adverse reactions
  • Start dosing at the low end of the dosing range and monitor for adverse effects